UBS upgraded Blue Owl Capital to Buy from Neutral with a price target of $22, up from $18. The analyst cites “resilient” fundraising, successful listing of institutional private business development companies and a healthy start to the next GP Solutions vintage for the upgrade. Despite risks to Blue Owl’s 2025 target of a $1 dividend, the company’s direct lending, GP Solutions and real estate businesses are generally well positioned, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OWL:
- Blue Owl Capital price target raised to $22 from $20 at Piper Sandler
- Blue Owl Capital Inc’s New Share Price & Shareholder Rights Risk – A Cause for Worry?
- Blue Owl Capital Corporation Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.51 and NAV Per Share of $15.45; Increases Quarterly Dividend
- Blue Owl Capital Corporation III Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.58 and NAV Per Share of $15.56
- Blue Owl Capital price target raised to $20 from $17 at Deutsche Bank